Clinical Trials Logo

Clinical Trial Summary

Patients with kidney failure rely on dialysis for sodium and fluid removal. The importance of a sodium and fluid balance in patients with kidney disease is very important. Excess volume has been consistently associated with cardiovascular morbidity and mortality. Many peritoneal dialysis (PD) patients need large volumes of dextrose or Icodextrin based solutions to achieve fluid removal. Commonly used PD solutions also have high sodium concentrations to limit sugar absorption. These PD fluids can reduce the amount of sodium removed and may eventually lead to water retention over time with possible adverse outcomes. This research study is being conducted to determine if a single eight-hour dwell of intraperitoneal sodium-free 30% Icodextrin / 10% Dextrose solution is safe, tolerable and effective in achieving sodium and volume removal in PD patients.


Clinical Trial Description

This study is a phase 1 interventional study in Peritoneal Dialysis Patients. We will recruit 10 participants. This study involves one visit at the London Health Sciences Centre University Hospital lasting approximately 9 hours. Study participants will receive one in-center PD dwell, consisting of peritoneal instillation of a sodium-free 30% Icodextrin/10% dextrose solution via their Tenckhoff catheter; the solution will be dwelling in the study patient's peritoneal cavity for a maximum of 8 hours as tolerated, at the end of which the solution will be drained. Participants will be monitored during administration of the study solution, during dwell and up to one hour after the Peritoneal Dialysis fluid is drained. Study participants will also undergo: - Clinical blood pressure and heart rate monitoring: baseline + every 15 minutes for the first two hours; then every 30 minutes up until 1 hour post complete peritoneal solution drain - Continuous Finapress hemodynamic monitoring (until 1 hour post peritoneal solution drain) - Pain Monitoring throughout the study visit (Five point verbal scale and McGill Pain Questionnaire) - Blood collection: baseline, 1, 2, 4, 8 hours into the dwell and 1 hour after the end of drain - Peritoneal dialysate collection: 1, 2, 4, 8 hours into the dwell - Urine collection throughout visit. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05185999
Study type Interventional
Source Lawson Health Research Institute
Contact Christopher W McIntyre, MD/PHD
Phone 519-685-8500
Email [email protected]
Status Not yet recruiting
Phase Phase 1
Start date March 1, 2022
Completion date December 1, 2023

See also
  Status Clinical Trial Phase
Completed NCT00781690 - Reduction of Heparin Dose in Dialysis With Evodial System N/A
Completed NCT00806130 - Health Related Quality of Life and Cognitive Function Among Norwegian Dialysis Patients N/A
Completed NCT00153621 - Prevalence of Proteinuria and Chronic Kidney Disease in Pediatric HIV-Infected Patients N/A
Not yet recruiting NCT04013620 - CNI Transient Replacement by Belatacept From 3 to 12 Months Post Transplantation in Patients With Early Graft Dysfunction Phase 3
Withdrawn NCT03998917 - Pathophysiological Characterization of the Neuromuscular Function of a Population With Multiple Comorbidities Suffering From Chronic Renal Failure in Pre-dialysis.
Completed NCT02586376 - Effects of the Low-level Laser Therapy (LLLT) on Muscle Strength (MS) of the Patients With Kidneys Failure (KF) N/A
Completed NCT00794326 - Clinical Evaluation of Low Sodium Peritoneal Dialysis (PD) Solution on Hypertensive Patients Treated With PD Phase 3
Completed NCT03076528 - An Innovative Virtually Supervised Exercise for Dialysis Patients Phase 2
Completed NCT02513303 - Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes Phase 3
Unknown status NCT00788905 - Comparison of Conventional Dialysis and the Allient System N/A
Completed NCT00804453 - Evaluation of the Biocompatibility of Cartridge Blood Set Versus Standard Blood Line N/A
Completed NCT01085552 - Bioequivalence of a Single Subcutaneous Dose of Epoetin Beta in Healthy Japanese and Caucasian Male Subjects Phase 1
Completed NCT00694824 - Vascular Calcification's Risk Factors in Haemodialysis Patients
Completed NCT00074620 - A Clinical Study to Assess the Safety of PEG-Hirudin (SPP200) Compared to Heparin in Patients Who Are on Haemodialysis Phase 2
Completed NCT03437538 - Reduction Ratio and Clearance During Hemodialysis With MCO-filter Compared to HDF With Standard High-flux Filter N/A
Completed NCT01450670 - Observational Study of Kibow Biotics in Dialysis Patients
Terminated NCT00472082 - Early Conversion From Tacrolimus to Efalizumab Maintenance Therapy in Kidney Transplant Recipients Phase 1/Phase 2
Recruiting NCT03142529 - Traditional Chinese Medicine (TCM) Colon Dialysis Treats Non-dialysis End-Stage Kidney Disease Phase 1/Phase 2
Active, not recruiting NCT02913690 - Palm Tocotrienols in Chronic Hemodialysis (Malaysia) (PATCH) N/A
Recruiting NCT04882254 - Normothermic Machine Perfusion: an Additional Value for Kidney Transplant Outcomes? Phase 2